|
|
Location:Product Center > Introduction > TORCH |
|
|
TORCH 5 in 1 | | | |
| Cat. No: | 0 | Size: | 40 cassettes | Method: | Procedure: immunochromatography
| Principle: | Allow the cassette and the sample to reach to the room temperature prior to use. First, open the cassette’s pouch, put the cassette on a flat surface and mark appropriately. Use a micropipette to take 100uL sample of serum or plasma sample and put the sample directly into each sample wells (S) of the cassette. Wait for 20 to 25 minutes to observe the final result; the result after 25 minutes is invalid. | | | | CMV-IgM | | | |
| Cat. No: | E0301 | Size: | 96T/48T | Method: | one-step captured ELISA | Principle: | According to capture ELISA principle, the kit is coated by McAb against humanμchain, adding HRP–CMV antigene as tracer, indicated by TMB, and establish capture ELISA to detect TOXO antibody IgM in human serum or plasma. | | | | TOXO-IgM | | | |
| Cat. No: | E0303 | Size: | 48T/96T | Method: | one-step captured ELISA | Principle: | According to capture ELISA principle, the kit is coated by McAb against humanμchain, adding HRP–TOXO antigene as tracer, indicated by TMB, and establish capture ELISA to detect TOXO antibody IgM in human serum or plasma. | | | | RV-IgM | | | |
| Cat. No: | E0305 | Size: | 48T/96T | Method: | one-step captured ELISA | Principle: | According to capture ELISA principle, the kit is coated by McAb against humanμchain, adding HRP–RV antigene as tracer, indicated by TMB, and establish capture ELISA to detect RV antibody IgM in human serum or plasma. | | | | HSV-II-IgM | | | |
| Cat. No: | E0309 | Size: | 48T/96T | Method: | Capture ELISA | Principle: | The kit applies mouse anti-human IgM (anti-μ chain) monoclonal antibody-coated micro-well plate, horseradish peroxidase (HRP)-labelled genetically engineer expressed herpes simples virus (type II) specific antibodies as the tracer, TMB coloration system and the capture method to detect anti-herpes simples virus (type II) IgM antibodies in the human serum or plasma. It’s used for the auxiliary diagnosis of herpes simples virus (type II) infections. | | | | HSV I-IgG | | | |
| Cat. No: | 0 | Size: | 48/96 | Method: | ELISA | Principle: | This kit applies genetic engineering expressed HSV type I virus recombinant antigens-coated microplate, enzyme-labelled mouse anti-human IgG as the tracer and tetramethylbenzidine (TMB) as the coloration system, and uses indirect ELISA method to detect the HSV-I-IgG antigens in the human serum or plasma. Using polystyrene microplate wells as carriers, recombinant HSV type I virus antigens are coated onto solid carrier wells. After adding the testing sample and incubation, if HSV type I virus antibodies are present in the testing sample, then they will form antigen-antibodies complexes with the coated HSV type I virus antigens. Add superoxide enzyme-labelled mouse anti-human IgG complexes after washing and incubate to allow enzyme-labelled mouse anti-human IgG to combine with HSV type I virus IgG antibody complexes in the solid carrier wells, which form antigen-antibody-enzyme-labelled antigen complexes. Wash away any uncombined materials and add substrate system TMB-H2O2 prior to test the OD value. The OD value reflexes the concentration of HSV type I virus IgG in the testing sample, and if the OD value of the testing sample is below the cut off value, the test is considered as negative and if above the cut off value, then the test is considered as positive.
| | | | HSV II-IgG | | | |
| Cat. No: | 0 | Size: | 48/96 | Method: | Capture ELISA | Principle: | The indirect ELISA assay kit using recomposed genetic HSV II type antigen coated on microplate, with mouse against human enzyme marker as a tracer plus TMB color showing system to detect antibody of HSV II-IgG within human serum or plasma | | | | HSV I-IgM | | | |
| Cat. No: | 0 | Size: | 48/96 | Method: | Capture ELISA | Principle: | This test applies the Capture ELISA principle and uses mouse anti-human IgM (Anti-μ chain) monoclonal antibody-coated micro-well plate as the solid carrier. It can capture herpes simples virus (HSV)-I IgM antibodies in a sample, and uses horseradish peroxidase-labelled HSV-I antigens as the tracer and TMB coloration system. If a sample contains HSV-I IgM antibodies, they will react with labelled antigens, otherwise, no color will show. Use a micro-plate reader to test the sample absorbance (OD value) in order to determine the presence of HSV-I IgM antibodies in the human serum or plasma. If the sample’s tested OD value is lower than the cutoff value, then the test is determined as negative, whereas if the OD value is higher than the cutoff value, the the test is determined as positive. Therefore this kit can detect serum samples that contain herpes simples virus type I IgM antibodies | | | | B19-IgM | | | |
| Cat. No: | 0 | Size: | 48/96 | Method: | Capture ELISA | Principle: | This kit employs the capture ELISA method for the detection of Parvovirus B19 antibodies. Using a mouse anti-human monoclonal antibodies IgM-coated microtiter plate, HRP-labelled genetically engineered recombinant Parvovirus B19 specific antigens as a tracer and TMB coloring system, this test employs a two-step reaction method to detect Parvovirus B19 antibodies in the testing sample. | | | | CMV-IgG | | | |
| Cat. No: | 0 | Size: | 48/96 | Method: | ELISA | Principle: | According to indirect method ELISA principle, the kit is coated by recomposed CMV antigen on microplate, adding enzyme antigen marker of mouse anti-human antibody IgG as tracer, indicated by TMB, and establish indirect ELISA to detect CMV antibody IgG in human serum or plasma.
| | | |
|
|
|
|
|